is tirzepatide approved in canada Mounjaro Now Available Health Canada approves Mounjaro (tirzepatide)

When microdosing is used within a structured medical program it can support subtle refinements improved adherence and steadier energy

[20] [21] Seek urgent medical advice if you are already taking a GLP-1 medication and experience: Severe, persistent abdominal pain (possible pancreatitis) A new lump in your neck or changes in your voice Symptoms of severe hypoglycaemia (if taking other diabetes medications) Signs of thyroid dysfunction despite stable levothyroxine therapy Persistent vomiting leading to dehydration or inability to take oral medications Severe right upper abdominal pain, fever or jaundice (possible gallbladder disease) Open communication with your healthcare team ensures that treatment decisions are individualised, evidence-based, and aligned with your health priorities

Retatrutide Injections: UK Guide to Administration, Dosing, and Safety Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously a mechanism designed to support weight management and improve metabolic health

Neurotrophic effects of intermittent fasting, calorie restriction and exercise: a review and annotated bibliography

Danilovic DL, Bloise W, Knobel M, Marui S

GLP-1s shouldnt be viewed as short-term fixes either, the editorial says